financetom
Business
financetom
/
Business
/
Lazard Insider Sold Shares Worth $473,593, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lazard Insider Sold Shares Worth $473,593, According to a Recent SEC Filing
Mar 20, 2026 1:56 AM

04:38 AM EDT, 03/20/2026 (MT Newswires) -- Christopher Hogbin, Chief Executive Officer of Asset Management, on March 17, 2026, sold 11,829 shares in Lazard ( LAZ ) for $473,593. Following the Form 4 filing with the SEC, Hogbin has control over a total of 11,829 common shares of the company, with 11,829 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1311370/000162828026019947/xslF345X05/wk-form4_1773963452.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Adidas could not match Nike's offer for Germany soccer federation, CEO says
Adidas could not match Nike's offer for Germany soccer federation, CEO says
Apr 30, 2024
LONDON, April 30 (Reuters) - Adidas CEO Bjorn Gulden said the German brand could not match Nike's ( NKE ) offer for Germany's national soccer federation sponsorship, after the U.S. company beat Adidas on its home turf last month to end its 70-year partnership with the federation. Nike ( NKE ) outbid Adidas to become the official supplier for the...
T-Mobile US Unit Plans Euro-Denominated Senior Notes Offering
T-Mobile US Unit Plans Euro-Denominated Senior Notes Offering
Apr 30, 2024
05:20 AM EDT, 04/30/2024 (MT Newswires) -- T-Mobile US ( TMUS ) said Tuesday that its T-Mobile USA unit plans to offer euro-denominated senior notes through a registered public offering, subject to market and other conditions. The unit plans to use the proceeds for general working capital, which could cover dividends, share repurchases, and debt refinancing, T-Mobile US ( TMUS...
Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies
Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies
Apr 30, 2024
05:34 AM EDT, 04/30/2024 (MT Newswires) -- Evotec (EVO) and Bayer said Tuesday that they are shifting their 12-year collaboration to focus on the development of new treatments for cardiovascular diseases. No financial terms were disclosed. Under the agreement, the companies said they will each contribute drug targets and technology platforms to create new treatment options to build a set...
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Apr 30, 2024
April 30 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Tuesday: ** Japan's Ono Pharmaceutical Co ( OPHLF ) said its $2.4 billion takeover of Deciphera Pharmaceuticals ( DCPH ) is a first step in expanding in U.S. and European markets. ** Satellite company SES has agreed to buy all the shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved